Industry Insights

  1. Integrating Excipients Into QbD For Drug Development: Understanding Drift & Critical Material Attributes 3/3/2021

    This article is the second in a three-part series based on information from the new guide Incorporation of Pharmaceutical Excipients into Product Development using Quality-by-Design, published by the International Pharmaceutical Excipients Council Federation (IPEC Federation). Learn about product, process, and excipient drift, as well as critical material attributes.

  2. 7 Reasons You're Not Ready For Risk Based Monitoring 10/10/2017

    You recently attended a clinical research conference, webinar, or sales pitch on risk based monitoring (RBM). Or your clinical team is putting together a strategy for a new trial and wants to implement RBM. Everyone you talk to is raving about efficiencies, cost savings, and how it’s the future of clinical research. Or maybe people are telling you how hard it is to implement RBM.

  3. Continuous Or Batch: The Best Solution For Your Oral Solid Dose Product

    Gaining a better understanding of continuous manufacturing and its fitness for your OSD product could secure more control over the quality and safety of your product and, ultimately, the future of its success.

  4. Mastering Upstream Development: Key Considerations For mAb Production 5/22/2024

    Selecting the right cell line is crucial in upstream development. Delve into key considerations that researchers and manufacturers must keep in mind to achieve high-quality and high-yield mAbs.

  5. Pharmaceutical Cold Chain Expertise — A Missing CDMO Ingredient?

    What if CMOs/CMDOs could offer a true end-to-end solution by ensuring strict temperature control of their products in transit? What impact would these solutions have on pharma customers?

  6. 3 Critical Areas To Review In Strategic Site Selection 8/8/2019

    Have you ever put off doing something you knew needed to be done, even though you had the ability and money for it?  Think exercising, getting a will or going to the dentist (hopefully you have dealt with at least the latter).  In the same way, many study sponsors put off aggregating and utilizing key intelligence on their previously used investigator sites for use in future strategic site selections. At times, there will be unique reasons for engaging with a certain investigator site or the need to use research-naive sites. However, if previously used sites will be considered for a new study, it is vital to review some key information for a truly strategic site selection process.  Let's take a look at some of these key, yet often forgotten, areas.

  7. A Snapshot Of What Pfizer's Doing With Teleoperated Robots 3/12/2025

    A robotic arm controlled with a virtual reality headset and input devices could aid in complex interventions where automation isn't practical.

  8. Examining Medtech's Booming Heart Valve Market 8/22/2018

    Transcatheter mitral valve devices will continue to expand into clinical practice as people age out of open-heart surgical operations, and technology and innovation for mitral valve diseases will continue to improve.

  9. Outlining The Trends And Challenges In The Inhaled Drug Delivery Market 10/21/2024

    Explore the latest trends and solutions in inhaled drug delivery, with a focus on overcoming dry powder formulation challenges to advance next-generation therapeutics.

  10. Bordering On Myth: Controlled Substances And The Canadian Border 12/9/2015

    There is a common misconception that controlled substances won’t be allowed to cross the Canadian border, thus preventing some pharmaceutical products from being produced by Canadian contract manufacturing facilities. We need to move past this fallacy.